Podcasts Other POEM of the Week Podcast Episode 550: SGLT2 inhibitors ("-flozin" meds) improve all-cause and CV mortality in patients regardless of diabetes or HF status

Episode 550: SGLT2 inhibitors ("-flozin" meds) improve all-cause and CV mortality in patients regardless of diabetes or HF status

Published: March 1, 2021, 4 a.m.

Dr. Ebell and Dr. Wilkes discuss the POEM titled ' SGLT2 inhibitors ("-flozin" meds) improve all-cause and CV mortality in patients regardless of diabetes or HF status '